• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乳酸星形疏水改性海藻酸钠的药物释放性能

[Drug release properties of sodium alginate hydrophobically modified by star polylactic acid].

作者信息

Ma Fu-Wen, Jin Yong, Zhang Wen-Fang, Zhou Shao-Bing, Ni Cai-Hua

机构信息

School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, China.

出版信息

Yao Xue Xue Bao. 2010 Nov;45(11):1447-51.

PMID:21361047
Abstract

Inorganic/polymer hybrid star polylactic acid (POSS-PLA) was obtained through ring-opening polymerization of lactide by using polyhydroxyl cage silsesquioxane (POSS-OH) as the core and tin (II) octoate as the catalyst. The star polylactic acid (POSS-PLA) was used to modify sodium alginate hydrophobically and a drug carrier was obtained. The drug release behavior was investigated by using ibuprofen as the model drug. The results showed that the drug loading rate could be improved and the release rate was postponed with an increase of POSS-PLA content in the carries. The release mechanism gradually changed from the first-order to the zero-order pattern after the modification.

摘要

以多羟基笼型倍半硅氧烷(POSS-OH)为核、辛酸亚锡为催化剂,通过丙交酯的开环聚合反应制备了无机/聚合物杂化星形聚乳酸(POSS-PLA)。用星形聚乳酸(POSS-PLA)对海藻酸钠进行疏水改性,得到一种药物载体。以布洛芬为模型药物研究了其释药行为。结果表明,随着载体中POSS-PLA含量的增加,载药量提高,释放速率延缓。改性后释放机制逐渐由一级模式转变为零级模式。

相似文献

1
[Drug release properties of sodium alginate hydrophobically modified by star polylactic acid].聚乳酸星形疏水改性海藻酸钠的药物释放性能
Yao Xue Xue Bao. 2010 Nov;45(11):1447-51.
2
Drug release behavior of poly (lactic-glycolic acid) grafting from sodium alginate (ALG-g-PLGA) prepared by direct polycondensation.通过直接缩聚法制备的海藻酸钠接枝聚乳酸-乙醇酸共聚物(ALG-g-PLGA)的药物释放行为。
J Biomater Sci Polym Ed. 2015;26(16):1152-62. doi: 10.1080/09205063.2015.1080456. Epub 2015 Aug 27.
3
Biomineralized hydrophobically modified alginate membrane for sustained drug delivery.用于持续药物递送的生物矿化疏水改性藻酸盐膜
J Control Release. 2011 Nov 30;152 Suppl 1:e79-81. doi: 10.1016/j.jconrel.2011.08.136.
4
Hydrophobic modification of sodium alginate and its application in drug controlled release.海藻酸钠的疏水改性及其在药物控制释放中的应用。
Bioprocess Biosyst Eng. 2010 May;33(4):457-63. doi: 10.1007/s00449-009-0349-2. Epub 2009 Jul 4.
5
Hydrophobically modified biomineralized polysaccharide alginate membrane for sustained smart drug delivery.用于持续智能药物输送的疏水性改性生物矿化多糖海藻酸盐膜。
Int J Biol Macromol. 2012 Apr 1;50(3):747-53. doi: 10.1016/j.ijbiomac.2011.12.003. Epub 2011 Dec 17.
6
Alginate-PLL cell encapsulation system Co-entrapping PLGA-microspheres for the continuous release of anti-inflammatory drugs.藻酸盐-多聚赖氨酸细胞包封系统共包埋 PLGA 微球用于抗炎药物的持续释放。
Biomed Microdevices. 2009 Oct;11(5):1103-13. doi: 10.1007/s10544-009-9327-3. Epub 2009 Jun 11.
7
Properties and active substance release kinetics from gelatin-alginate matrices.明胶-海藻酸盐基质的性质及活性物质释放动力学
Polim Med. 2006;36(3):55-69.
8
Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.作为抗菌药物吖啶黄控释的兽用给药系统的粘膜粘附阴道片
AAPS PharmSciTech. 2002;3(3):E20. doi: 10.1208/pt030320.
9
Electrophoretic deposition of antibiotic loaded PHBV microsphere-alginate composite coating with controlled delivery potential.载抗生素 PHBV 微球-海藻酸钠复合涂层的电泳沉积及其控释性能。
Colloids Surf B Biointerfaces. 2015 Jun 1;130:199-206. doi: 10.1016/j.colsurfb.2015.04.009. Epub 2015 Apr 9.
10
Controlling protein release from scaffolds using polymer blends and composites.使用聚合物共混物和复合材料控制支架中的蛋白质释放。
Eur J Pharm Biopharm. 2008 Jan;68(1):82-9. doi: 10.1016/j.ejpb.2007.05.023. Epub 2007 Jul 18.

引用本文的文献

1
Star-Shaped and Linear POSS-Polylactide Hybrid Copolymers.星型和线性倍半硅氧烷-聚丙交酯杂化共聚物
Materials (Basel). 2015 Jul 17;8(7):4400-4420. doi: 10.3390/ma8074400.
2
Bio-mimetic drug delivery systems designed to help the senior population reconstruct melatonin plasma profiles similar to those of the healthy younger population.旨在帮助老年人群重建与健康年轻人群相似的褪黑素血浆水平的仿生药物递送系统。
Acta Pharm Sin B. 2014 Feb;4(1):60-6. doi: 10.1016/j.apsb.2013.12.006. Epub 2014 Jan 23.